CenterBook Partners’s Merck MRK Stock Holding History

CenterBook Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,451	Closed	-$2.47M	–	639
2025 Q3	$2.47M	Buy	+29,451	New	+$2.43M	0.12%	225
2025 Q2	–	Sell	-4,146	Closed	-$372K	–	565
2025 Q1	$372K	Buy	+4,146	New	+$387K	0.02%	433

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CenterBook Partners's MRK Position: Q4 2025 in Review

CenterBook Partners sold out of Merck (MRK) in Q4 2025, closing a stake of 29,451 shares — an estimated $2.47M sold.

CenterBook Partners first reported a position in MRK in Q1 2025 and held it in 2 quarters. The position peaked at $2.47M in Q3 2025. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

CenterBook Partners reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
CenterBook Partners sold 29,451 Merck shares in Q4 2025, an estimated $2.47M.
CenterBook Partners first reported a position in Merck in Q1 2025 and held it in 2 quarters.
CenterBook Partners's Merck position peaked at $2.47M in Q3 2025.
3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on CenterBook Partners's 13F filing for Q4 2025, filed 11 Feb 2026.